Medtronic’s (MDT) Heart Devices Are Suddenly Outgrowing The Rest Of Med-Tech

Medtronic released fiscal 2027 first-quarter earnings on September 1, posting revenue of $9.8 billion and organic growth of 13.7%, exceeding company guidance. The quarter ended July 31 and included an extra selling week that contributed approximately $570 million to the revenue figure. Management characterized the underlying performance as the strongest quarterly result in nearly eight years and raised its full-year outlook based on the beat.
Cardiovascular revenue grew 18.9% organically to $3.